Can-Fite BioPharma (CANF) Balance Sheet: Assets & Liabilities

Can-Fite BioPharma (CANF) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Can-Fite BioPharma reported total assets of $9.51M and total liabilities of $3.92M. Shareholders' equity was $5.59M, up 2.9% from $5.44M a year earlier. Total debt stood at $71.00K against $8.54M in cash and short-term investments, a net cash position of $8.47M. That puts debt-to-equity at 0.01, compared with 0.02 a year earlier.

Can-Fite BioPharma Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Can-Fite BioPharma Ltd. (CANF) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	5.53	4.83	4.83	4.28	2.98	4.39	8.27	2.70	3.62	3.50
Short-Term Investments	3.01	3.06	3.06	4.64	5.00	14.51	0.08	0.06	0.27	0.00
Cash & Short-Term Investments	8.54	7.89	7.89	8.92	7.98	19.14	8.34	2.76	3.89	3.50
Accounts Receivable	0.07	0.00	-	0.00	0.05	0.05	0.02	0.64	0.00	0.00
Inventory	0.00	0.00	-	0.00	-0.04	-0.05	0.00	-0.72	-3.97	-3.30
Other Current Assets	0.83	2.11	1.10	0.99	1.17	0.93	1.04	4.46	4.02	3.09
Total Current Assets	9.44	8.98	8.98	9.91	9.16	20.07	9.40	7.14	7.90	6.87
Non-Current Assets
Property, Plant & Equipment (Net)	0.07	0.14	0.14	0.08	0.13	0.19	0.12	0.12	0.05	0.05
Long-Term Investments	0.00	0.00	-	0.00	0.01	0.00	0.00	0.00	0.00	0.91
Other Non-Current Assets	0.00	0.00	-	0.00	-0.01	0.00	0.00	0.91	0.00	0.01
Total Non-Current Assets	0.07	0.14	0.14	0.08	0.13	0.19	0.12	1.03	0.05	0.97
Total Assets	9.51	9.12	9.12	9.99	9.28	20.25	9.52	8.17	7.95	7.83
Current Liabilities
Accounts Payable	1.16	0.62	0.62	0.43	0.90	0.95	0.56	2.16	1.07	0.43
Short-Term Debt	0.06	0.05	-	0.03	0.05	0.05	0.04	0.04	0.00	0.00
Accrued Liabilities	1.11	-	0.98	0.25	0.78	0.91	0.33	-	-	-
Deferred Revenue	0.40	0.41	0.41	0.62	0.78	0.82	0.33	0.47	0.93	0.37
Other Current Liabilities	1.11	0.98	-	0.94	0.78	0.91	0.33	0.61	1.12	1.04
Total Current Liabilities	2.73	2.05	2.05	2.02	2.50	2.73	1.27	3.27	3.12	1.80
Non-Current Liabilities
Long-Term Debt	0.01	0.05	0.05	0.01	0.01	0.07	0.02	0.04	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	-	0.00	-2.30	-3.07	-2.16	-2.42	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	1.58	1.71	2.30	3.07	2.16	1.57	0.00	2.14
Total Non-Current Liabilities	1.19	1.63	1.63	1.73	2.31	3.14	2.18	2.46	1.82	2.98
Total Liabilities	3.92	3.68	3.68	3.75	4.81	5.87	3.45	5.73	4.94	4.78
Stockholders' Equity
Common Stock	0.00	0.00	-	0.00	0.00	60.65	33.04	8.23	2.64	2.39
Retained Earnings	-176.19	-166.36	-166.36	-158.48	-150.85	-140.67	-125.47	-110.31	-100.62	-105.66
Accumulated Other Comprehensive Income	1.13	1.13	1.13	1.13	1.13	1.13	1.13	1.13	6.93	6.28
Additional Paid-in Capital	180.65	170.67	170.67	163.60	154.19	153.93	97.38	103.40	94.08	87.96
Shares Outstanding	2.62	-	0.99	0.45	0.27	815.75	-	-	-	-
Total Stockholders' Equity	5.59	5.44	5.44	6.24	4.47	14.38	6.07	2.44	3.02	3.05
Total Liabilities & Equity	9.51	9.12	9.12	9.99	9.28	20.25	9.52	8.17	7.95	7.83

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Can-Fite BioPharma Balance Sheet

How much debt does Can-Fite BioPharma have?

Can-Fite BioPharma had total debt of $71.00K as of Dec 31, 2025, against $8.54M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $104.00K a year earlier.

What are Can-Fite BioPharma's total assets?

Can-Fite BioPharma reported total assets of $9.51M as of Dec 31, 2025, up 4.3% from $9.12M a year earlier. Total liabilities were $3.92M.

What is Can-Fite BioPharma's shareholders' equity?

Can-Fite BioPharma's shareholders' equity was $5.59M as of Dec 31, 2025, or about $2.14 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition